(Q62105023)
Statements
A Phase I/II Study of Flavopiridol Administered as a 30-Minute Bolus Followed by a 4-Hour Infusion in Lymphomas and Multiple Myeloma (English)
0 references
December 2005
0 references
February 2011
0 references
46
0 references